Treatment of Status Epilepticus
Immediately administer intravenous lorazepam 4 mg at 2 mg/min (or 0.1 mg/kg) as first-line treatment, followed by a second-line anticonvulsant agent if seizures persist after 5-10 minutes. 1, 2, 3
Immediate First-Line Treatment: Benzodiazepines
- Lorazepam 4 mg IV at 2 mg/min is the preferred initial agent, with 64.9% efficacy in terminating overt generalized convulsive status epilepticus 3, 2
- If seizures continue after 10-15 minutes, administer a second dose of lorazepam 4 mg IV 2
- Alternative routes when IV access unavailable: IM midazolam 0.2 mg/kg (maximum 6 mg) or intranasal midazolam 1, 4
- Have airway equipment immediately available before administering any benzodiazepine, as respiratory depression can occur 1, 2
Critical concurrent action: Check fingerstick glucose immediately and correct hypoglycemia while administering benzodiazepines 1
Second-Line Treatment (If Seizures Persist After Benzodiazepines)
Administer ONE of the following second-line agents immediately - do not delay for neuroimaging 1:
Preferred Second-Line Options:
- Valproate 20-30 mg/kg IV over 5-20 minutes: 88% efficacy with 0% hypotension risk - superior safety profile compared to phenytoin 1
- Levetiracetam 30 mg/kg IV over 5 minutes: 68-73% efficacy with minimal cardiovascular effects, no cardiac monitoring required 1
- Fosphenytoin 20 mg PE/kg IV at maximum rate of 150 PE/min: 84% efficacy but 12% hypotension risk requiring continuous ECG and blood pressure monitoring 1
- Phenobarbital 20 mg/kg IV over 10 minutes: 58.2% efficacy but higher risk of respiratory depression 1
Valproate appears to be the optimal second-line choice due to superior safety profile (no hypotension) while maintaining equivalent efficacy to fosphenytoin 1
Refractory Status Epilepticus (Seizures Continuing Despite Benzodiazepines + One Second-Line Agent)
Initiate continuous EEG monitoring at this stage and proceed to anesthetic agents 1:
Third-Line Anesthetic Agents:
Midazolam infusion (first choice for refractory SE):
Propofol (requires mechanical ventilation):
Pentobarbital (most effective but highest risk):
Essential Concurrent Management Throughout Treatment
Simultaneously search for and treat reversible causes 1:
- Hypoglycemia (check fingerstick glucose immediately)
- Hyponatremia and other electrolyte abnormalities
- Hypoxia (maintain airway, provide oxygen)
- Drug toxicity or withdrawal syndromes
- CNS infection (meningitis, encephalitis)
- Ischemic stroke or intracerebral hemorrhage
- Metabolic derangements
Critical Monitoring Requirements
- Continuous vital sign monitoring, particularly respiratory status and blood pressure 1, 4
- Prepare for mechanical ventilation before initiating any anesthetic agent 1
- Continuous EEG monitoring for refractory cases to guide titration and detect non-convulsive seizure activity 1
Common Pitfalls to Avoid
- Never use neuromuscular blockers alone (e.g., rocuronium) - they only mask motor manifestations while allowing continued electrical seizure activity and brain injury 1
- Do not skip to third-line agents until benzodiazepines and at least one second-line agent have been tried 1
- Do not delay anticonvulsant administration for neuroimaging - CT scanning can be performed after seizure control is achieved 1
- Nothing should be put in the mouth and no oral medications should be given during active seizures 5
- Do not restrain the patient - instead, help them to the ground, place in recovery position, and clear the area 5
Activation of Emergency Medical Services
Activate EMS immediately for 5:
- First-time seizure
- Seizures lasting >5 minutes
- Multiple seizures without return to baseline between episodes
- Seizures in water, with traumatic injuries, difficulty breathing, or choking
- Seizure in infant <6 months or pregnant individuals
- Patient not returning to baseline within 5-10 minutes after seizure stops